[go: up one dir, main page]

DE60117467D1 - Famotidin-injektionen - Google Patents

Famotidin-injektionen

Info

Publication number
DE60117467D1
DE60117467D1 DE60117467T DE60117467T DE60117467D1 DE 60117467 D1 DE60117467 D1 DE 60117467D1 DE 60117467 T DE60117467 T DE 60117467T DE 60117467 T DE60117467 T DE 60117467T DE 60117467 D1 DE60117467 D1 DE 60117467D1
Authority
DE
Germany
Prior art keywords
famotidine
injections
impairing
absorption
far
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60117467T
Other languages
English (en)
Other versions
DE60117467T2 (de
Inventor
Katsunori Nakata
Hiroshi Yatabe
Tsukasa Nishikawahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DE60117467D1 publication Critical patent/DE60117467D1/de
Publication of DE60117467T2 publication Critical patent/DE60117467T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fishing Rods (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
DE60117467T 2000-12-22 2001-12-20 Famotidin-injektionen Expired - Lifetime DE60117467T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000389887 2000-12-22
JP2000389887 2000-12-22
PCT/JP2001/011171 WO2002051411A1 (fr) 2000-12-22 2001-12-20 Injections de famotidine

Publications (2)

Publication Number Publication Date
DE60117467D1 true DE60117467D1 (de) 2006-04-27
DE60117467T2 DE60117467T2 (de) 2006-09-28

Family

ID=18856345

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60117467T Expired - Lifetime DE60117467T2 (de) 2000-12-22 2001-12-20 Famotidin-injektionen

Country Status (12)

Country Link
US (1) US7094414B2 (de)
EP (1) EP1352654B1 (de)
JP (1) JP3648531B2 (de)
KR (1) KR100848794B1 (de)
CN (1) CN100438871C (de)
AT (1) ATE318599T1 (de)
CA (1) CA2432037C (de)
DE (1) DE60117467T2 (de)
DK (1) DK1352654T3 (de)
ES (1) ES2259313T3 (de)
PT (1) PT1352654E (de)
WO (1) WO2002051411A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040185119A1 (en) * 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
US20100105638A1 (en) * 2007-03-12 2010-04-29 Kerstin Den-Braven Cosmetic compositions
US8058296B2 (en) * 2008-11-25 2011-11-15 Richard Tokunaga Treatment and prevention of deleterious effects associated with alcohol consumption
JP2013503853A (ja) * 2009-09-04 2013-02-04 ムニセクハー メダサニ， 神経変性または神経・筋変性疾患の治療方法およびその治療薬
CN101972248B (zh) * 2010-10-09 2012-02-01 江苏奥赛康药业股份有限公司 一种供注射用的法莫替丁组合物及其制备方法
CN103446048A (zh) * 2013-09-12 2013-12-18 南京正宽医药科技有限公司 一种法莫替丁注射液及其制备方法
CN103877579B (zh) * 2014-03-24 2015-08-26 海南双成药业股份有限公司 一种含有法莫替丁的药物组合物及其制剂
WO2017091166A1 (en) 2015-11-26 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Stable pharmaceutical compositions and process for their preparation
JP7090845B2 (ja) * 2018-08-03 2022-06-27 高田製薬株式会社 パロノセトロン含有液体組成物
CN111904936B (zh) * 2020-08-28 2022-07-19 开封康诺药业有限公司 一种法莫替丁冻干粉针剂
CN113197869A (zh) * 2021-04-13 2021-08-03 河北智同生物制药股份有限公司 一种注射用法莫替丁冻干粉针剂及制备方法
CN116898796A (zh) * 2022-04-20 2023-10-20 广州远跖恒创医药科技有限公司 一种法莫替丁注射液的制备方法
WO2024062287A1 (en) * 2022-09-21 2024-03-28 Maiva Pharma Private Limited A premixed room temperature stable composition of famotidine for intravenous bolus injection and method thereof
CN115737548B (zh) * 2022-11-21 2024-12-27 四川汇宇制药股份有限公司 一种法莫替丁注射液的制备方法
CN115957182A (zh) * 2022-12-27 2023-04-14 成都康泰源医药科技有限责任公司 一种法莫替丁注射液及其制备方法
CN116059163A (zh) * 2023-02-13 2023-05-05 河北智恒医药科技股份有限公司 一种法莫替丁注射液的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4612756B1 (de) 1969-09-22 1971-04-01
JPS58103312A (ja) 1981-12-15 1983-06-20 Yamanouchi Pharmaceut Co Ltd 難溶性医薬品の注射剤用水溶液
US4684630A (en) * 1983-08-24 1987-08-04 Repta Arnold J Method of parenterally delivering drugs and related compositions
TW280770B (de) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
US5650421A (en) * 1995-03-31 1997-07-22 Baxter International Inc. Premixed famotidine formulation
JP3213283B2 (ja) 1997-10-16 2001-10-02 山之内製薬株式会社 注射剤
AU718356B2 (en) 1998-01-12 2000-04-13 Panacea Biotec Limited A parenteral water-miscible non-intensely coloured injectable composition of non-steroidal anit-inflammatory drugs
PT1052975E (pt) * 1998-02-10 2007-10-29 Sicor Inc Composição de propofol que contém sulfito

Also Published As

Publication number Publication date
CA2432037A1 (en) 2002-07-04
DE60117467T2 (de) 2006-09-28
CN1482910A (zh) 2004-03-17
JPWO2002051411A1 (ja) 2004-04-22
WO2002051411A1 (fr) 2002-07-04
ES2259313T3 (es) 2006-10-01
CN100438871C (zh) 2008-12-03
CA2432037C (en) 2008-08-12
US20040067993A1 (en) 2004-04-08
PT1352654E (pt) 2006-06-30
JP3648531B2 (ja) 2005-05-18
DK1352654T3 (da) 2006-07-03
KR100848794B1 (ko) 2008-07-28
EP1352654B1 (de) 2006-03-01
EP1352654A4 (de) 2005-01-19
EP1352654A1 (de) 2003-10-15
US7094414B2 (en) 2006-08-22
KR20030063457A (ko) 2003-07-28
ATE318599T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
DE60117467D1 (de) Famotidin-injektionen
ATE306925T1 (de) Minoxidil enthaltende zubereitung
DK1455782T3 (da) Höjkoncentrerede stabile meloxicamoplösninger til injektion uden nåle
DK0431663T3 (da) Stabiliserende opløsninger af psykotrope midler
PT1349856E (pt) Compostos de isoindolina-1-ona activadores da glicocinase
DE60117605D1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie
DE60329237D1 (de) Kristalline form von linezolid
BR0208970B1 (pt) produto absorvente com ajuste melhorado.
ID26055A (id) Senyawa-senyawa hidroksidifenil eter
BR0208969B1 (pt) produto absorvente com ajuste melhorado.
ATE297222T1 (de) Zusammensetzungen enthaltend eine niedrige konzentration an peroxide zur behandlung von vaginitis
ATE512208T1 (de) Duftstoffkombination enthaltend 3, 7-dymethyl-6- en-nitril (citronellyl nitril) als geranonitril- substitut
DK0843967T3 (da) Anvendelse af beta-aminopripionsyrederivater som fungicider
ATE382369T1 (de) Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens
DE60117938D1 (de) Vorspannen von Bauteilen
AR057566A1 (es) 2- acilaminotiazol -4- carboxamidas insecticidas
ATE437578T1 (de) Riechstoff- und geschmackstoffzusammensetzungen
DK0949221T3 (da) Sammensætning, som er egnet som flydende gödning og som indeholder svovl i form af kaliumtetrathionat
EE200200532A (et) Intravenoosselt manustatava linesoliidi lahuse mahuti
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure
BR0206922A (pt) Compostos orgânicos
ATE280802T1 (de) Thermisch stabilisierte pvc-zusammensetzungen
ATE368463T1 (de) Minoxidil-enthaltende flüssige zusammensetzung
ES2190921T3 (es) 4-alcanoil-3-tiazolinas y su empleo como perfumes y aromas.
BR0113202A (pt) Compostos de trioxepano

Legal Events

Date Code Title Description
8364 No opposition during term of opposition